Weight Loss Treatments
US$ 21.55
rfk glp-1 Jr speaks on weight loss drug prices in Oval Office RFK Jr. Walks a Tightrope
Description
Eli Lilly's GIP/GLP-1 Dual Agonist Tirzepatide: Lowering Blood Sugar, Weight, And Cardiovascular Risk!,Industry news
![Figure][1] ### Competing Interest Statement The authors have declared no competing interest
Nutrient Gaps
As demand for GLP-1 weight-loss solutions grows, prescription-free alternatives are getting a lot of attention
One of the largest US health insurers is ending coverage of GLP-1 weight-loss drugs for its employees but will continue covering them for people with type 2 diabetes.
